0001225208-11-011386.txt : 20110406
0001225208-11-011386.hdr.sgml : 20110406
20110406125916
ACCESSION NUMBER: 0001225208-11-011386
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110404
FILED AS OF DATE: 20110406
DATE AS OF CHANGE: 20110406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENZYME CORP
CENTRAL INDEX KEY: 0000732485
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 061047163
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6172527500
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WHITWORTH RALPH V
CENTRAL INDEX KEY: 0001052622
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14680
FILM NUMBER: 11742600
MAIL ADDRESS:
STREET 1: RELATIONAL INVESTORS LLC
STREET 2: 12400 HIGH BLUFF DRIVE, SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
X0303
4
2011-04-04
0000732485
GENZYME CORP
GENZ
0001052622
WHITWORTH RALPH V
12400 HIGH BLUFF DR. #600
SAN DIEGO
CA
92130
1
Genzyme common stock (GENZ)
2011-04-04
4
M
0
2375.0000
0.0000
A
4750.0000
D
Genzyme common stock (GENZ)
2011-04-04
4
D
0
2375.0000
74.0000
D
2375.0000
D
Genzyme common stock (GENZ)
2011-04-04
4
U
0
10606248.0000
74.0000
D
0.0000
I
see footnotes (1) and (2)
Restricted Stock Units
0.0000
2011-04-04
4
M
0
2375.0000
0.0000
D
2011-06-16
Genzyme common stock (GENZ)
2375.0000
0.0000
D
Stock Option (right to buy)
52.6600
2011-04-04
4
D
0
7125.0000
51.5200
D
2010-06-16
2020-04-14
Genzyme common stock (GENZ)
7125.0000
0.0000
D
Stock Option (right to buy)
51.5200
2011-04-04
4
D
0
7125.0000
52.6600
D
2011-06-16
2020-06-16
Genzyme common stock (GENZ)
7125.0000
0.0000
D
The reporting person is one of the Principals of Relational Investors LLC ("RILLC"). RILLC is the record owner of 100 shares and sole general partner, or the sole managing member of the general partner, of Relational Investors, L.P., Relational Fund Partners, L.P., Relational Coast Partners, L.P., RH Fund 1, L.P., RH Fund 6, L.P., Relational Investors VIII, L.P., Relational Investors IX, L.P., Relational Investors X, L.P., Relational Investors XV, L.P., Relational Investors XVI, L.P., Relational Investors XX, L.P., Relational Investors XXII, L.P., Relational Investors XXIII, L.P., and Relational Investors Alpha Fund I, L.P.
The Limited Partnerships in footnote 1 own a total of 7,963,166 shares. An additional 2,234,482 shares are held in accounts managed by RILLC and an additional 408,500 shares are held through co-investment arrangements with certain entities listed in footnote 1. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
The vested restricted stock units were scheduled to vest on the date of the 2011 annual meeting of shareholders.
This option, which provided for vesting at the next annual meeting of shareholders, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.
Susan P. Cogswell, Attorney-in-Fact
2011-04-06